Nodding syndrome, a case-control study in Mahenge, Tanzania: Onchocerca volvulus and not Mansonella perstans as a risk factor.
Journal
PLoS neglected tropical diseases
ISSN: 1935-2735
Titre abrégé: PLoS Negl Trop Dis
Pays: United States
ID NLM: 101291488
Informations de publication
Date de publication:
Jun 2023
Jun 2023
Historique:
received:
10
02
2023
accepted:
05
06
2023
revised:
30
06
2023
medline:
3
7
2023
pubmed:
20
6
2023
entrez:
20
6
2023
Statut:
epublish
Résumé
Nodding syndrome (NS) has been consistently associated with onchocerciasis. Nevertheless, a positive association between NS and a Mansonella perstans infection was found in South Sudan. We aimed to determine whether the latter parasite could be a risk factor for NS in Mahenge. Cases of epilepsy were identified in villages affected by NS in Mahenge, Tanzania, and matched with controls without epilepsy of the same sex, age and village. We examined blood films of cases and controls to identify M. perstans infections. The participants were also asked for sociodemographic and epilepsy information, examined for palpable onchocercal nodules and onchocerciasis-related skin lesions and tested for anti-Onchocerca volvulus antibodies (Ov16 IgG4) by ELISA. Clinical characteristics of cases and controls, O. volvulus exposure status and relevant sociodemographic variables were assessed by a conditional logistic regression model for NS and epilepsy status matched for age, sex and village. A total of 113 epilepsy cases and 132 controls were enrolled, of which, respectively, 56 (49.6%) and 64 (48.5%) were men. The median age in cases and controls was 28.0 (IQR: 22.0-35.0) and 27.0 (IQR: 21.0-33.3) years. Of the persons with epilepsy, 43 (38.1%) met the probable NS criteria and 106 (93.8%) had onchocerciasis-associated epilepsy (OAE). M. perstans infection was absent in all participants, while Ov16 seroprevalence was positively associated with probable NS (odds ratio (OR): 5.05, 95%CI: 1.79-14.27) and overall epilepsy (OR: 2.03, 95%CI: 1-07-3.86). Moreover, onchocerciasis-related skin manifestations were only found in the cases (n = 7, p = 0.0040), including persons with probable NS (n = 4, p = 0.0033). Residing longer in the village and having a family history of seizures were positively correlated with Ov16 status and made persons at higher odds for epilepsy, including probable NS. In contrast to O. volvulus, M. perstans is most likely not endemic to Mahenge and, therefore, cannot be a co-factor for NS in the area. Hence, this filaria is unlikely to be the primary and sole causal factor in the development of NS. The main risk factor for NS remains onchocerciasis.
Sections du résumé
BACKGROUND
BACKGROUND
Nodding syndrome (NS) has been consistently associated with onchocerciasis. Nevertheless, a positive association between NS and a Mansonella perstans infection was found in South Sudan. We aimed to determine whether the latter parasite could be a risk factor for NS in Mahenge.
METHODS
METHODS
Cases of epilepsy were identified in villages affected by NS in Mahenge, Tanzania, and matched with controls without epilepsy of the same sex, age and village. We examined blood films of cases and controls to identify M. perstans infections. The participants were also asked for sociodemographic and epilepsy information, examined for palpable onchocercal nodules and onchocerciasis-related skin lesions and tested for anti-Onchocerca volvulus antibodies (Ov16 IgG4) by ELISA. Clinical characteristics of cases and controls, O. volvulus exposure status and relevant sociodemographic variables were assessed by a conditional logistic regression model for NS and epilepsy status matched for age, sex and village.
RESULTS
RESULTS
A total of 113 epilepsy cases and 132 controls were enrolled, of which, respectively, 56 (49.6%) and 64 (48.5%) were men. The median age in cases and controls was 28.0 (IQR: 22.0-35.0) and 27.0 (IQR: 21.0-33.3) years. Of the persons with epilepsy, 43 (38.1%) met the probable NS criteria and 106 (93.8%) had onchocerciasis-associated epilepsy (OAE). M. perstans infection was absent in all participants, while Ov16 seroprevalence was positively associated with probable NS (odds ratio (OR): 5.05, 95%CI: 1.79-14.27) and overall epilepsy (OR: 2.03, 95%CI: 1-07-3.86). Moreover, onchocerciasis-related skin manifestations were only found in the cases (n = 7, p = 0.0040), including persons with probable NS (n = 4, p = 0.0033). Residing longer in the village and having a family history of seizures were positively correlated with Ov16 status and made persons at higher odds for epilepsy, including probable NS.
CONCLUSION
CONCLUSIONS
In contrast to O. volvulus, M. perstans is most likely not endemic to Mahenge and, therefore, cannot be a co-factor for NS in the area. Hence, this filaria is unlikely to be the primary and sole causal factor in the development of NS. The main risk factor for NS remains onchocerciasis.
Identifiants
pubmed: 37339148
doi: 10.1371/journal.pntd.0011434
pii: PNTD-D-23-00174
pmc: PMC10313037
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
e0011434Informations de copyright
Copyright: © 2023 Amaral et al. This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Res Rep Trop Med. 2020 Oct 07;11:81-95
pubmed: 33117052
Acta Trop. 2021 Jun;218:105677
pubmed: 32857984
Parasit Vectors. 2015 Nov 25;8:604
pubmed: 26607993
Trans R Soc Trop Med Hyg. 1955 Sep;49(5):460-71
pubmed: 13267912
PLoS One. 2013 Jun 18;8(6):e66419
pubmed: 23823012
Brain Commun. 2022 Jun 06;4(3):fcac126
pubmed: 35694148
Parasitology. 2010 Sep;137(10):1559-68
pubmed: 20388236
Epileptic Disord. 2019 Oct 1;21(5):425-435
pubmed: 31649005
Neurology. 2015 May 5;84(18):1838-45
pubmed: 25841025
Trop Med Int Health. 2022 Aug;27(8):686-695
pubmed: 35653502
Trends Parasitol. 2023 Feb;39(2):126-138
pubmed: 36528471
Int J Infect Dis. 2016 Aug;49:1-8
pubmed: 27210267
Clin Exp Immunol. 1999 Jul;117(1):130-7
pubmed: 10403926
Res Rep Trop Med. 2021 May 24;12:93-105
pubmed: 34079424
Infect Dis Poverty. 2019 May 20;8(1):34
pubmed: 31109376
Trans R Soc Trop Med Hyg. 2009 Mar;103(3):274-9
pubmed: 19081121
PLoS Negl Trop Dis. 2020 Jul 8;14(7):e0008436
pubmed: 32639997
PLoS Negl Trop Dis. 2011 Jun;5(6):e1185
pubmed: 21666796
Appl Parasitol. 1996 Jan;37(1):32-7
pubmed: 8574245
Parasitology. 2006 Jun;132(Pt 6):843-54
pubmed: 16469200
Emerg Infect Dis. 2013;19(9):1374-84
pubmed: 23965548
Parasit Vectors. 2019 Apr 11;12(1):166
pubmed: 30975194
Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):537-41
pubmed: 12474484
Trans R Soc Trop Med Hyg. 2008 Feb;102(2):148-54
pubmed: 18082234
Med Microbiol Immunol. 2003 Feb;192(1):15-21
pubmed: 12592559
Lancet Neurol. 2013 Mar;12(3):253-63
pubmed: 23375964
PLoS Negl Trop Dis. 2021 Jan 7;15(1):e0008965
pubmed: 33411705
Qual Health Res. 2022 Aug;32(10):1544-1556
pubmed: 35549600
Pathogens. 2021 Oct 15;10(10):
pubmed: 34684277
Lancet Infect Dis. 2018 Nov;18(11):1278-1286
pubmed: 30268645
Pathogens. 2021 Dec 08;10(12):
pubmed: 34959543
Epilepsy Behav. 2021 Oct 28;124:108372
pubmed: 34757262
Am J Trop Med Hyg. 2012 Mar;86(3):557
pubmed: 22403337
Acta Trop. 1969;26(1):29-69
pubmed: 4397649
Epilepsia Open. 2017 Apr 26;2(2):145-152
pubmed: 29588943
Trop Geogr Med. 1970 Sep;22(3):345-51
pubmed: 5470901
PLoS Negl Trop Dis. 2022 Jan 31;16(1):e0009798
pubmed: 35100277
Lancet Neurol. 2014 Dec;13(12):1202-15
pubmed: 25453460
Pathogens. 2022 Sep 14;11(9):
pubmed: 36145478
Acta Trop. 2018 May;181:50-59
pubmed: 29410302
Res Rep Trop Med. 2018 Jan 18;9:9-24
pubmed: 30050351
Ann Trop Med Parasitol. 2005 Jun;99(4):383-93
pubmed: 15949186
PLoS Negl Trop Dis. 2016 May 03;10(5):e0004478
pubmed: 27139245
Seizure. 2020 Oct;81:151-156
pubmed: 32810838
Proc Natl Acad Sci U S A. 2005 Oct 18;102(42):15265-70
pubmed: 16217028
Infect Dis Poverty. 2018 Oct 8;7(1):79
pubmed: 30293530
Open Forum Infect Dis. 2020 Jun 02;7(6):ofaa206
pubmed: 32587878
J Travel Med. 2022 Nov 4;29(7):
pubmed: 35417002
Seizure. 2019 Aug;70:82-89
pubmed: 31323565
Epilepsy Behav. 2021 Mar;116:107773
pubmed: 33515932
MMWR Morb Mortal Wkly Rep. 2014 Jul 18;63(28):603-6
pubmed: 25029112
Pathogens. 2021 Nov 09;10(11):
pubmed: 34832607
Epilepsia. 2014 Apr;55(4):475-82
pubmed: 24730690
Afr Health Sci. 2012 Sep;12(3):242-8
pubmed: 23382736
Trop Med Infect Dis. 2021 Dec 11;6(4):
pubmed: 34941667
New Microbes New Infect. 2018 Sep 01;26:S19-S22
pubmed: 30402239
Seizure. 2018 Dec;63:93-101
pubmed: 30468964
Angew Parasitol. 1992 Nov;33(4):235-41
pubmed: 1456469
Trans R Soc Trop Med Hyg. 2006 May;100(5):458-63
pubmed: 16257021
Pathogens. 2020 Apr 24;9(4):
pubmed: 32344586
PLoS Negl Trop Dis. 2017 Feb 9;11(2):e0005201
pubmed: 28182652
Infect Dis Poverty. 2018 Jun 20;7(1):64
pubmed: 29921319
Tropenmed Parasitol. 1976 Jun;27(2):123-32
pubmed: 941247